Bryn Mawr Capital Management LLC Reduces Holdings in DaVita Inc. (NYSE:DVA)

Bryn Mawr Capital Management LLC lowered its stake in DaVita Inc. (NYSE:DVA - Free Report) by 61.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,340 shares of the company's stock after selling 2,160 shares during the period. Bryn Mawr Capital Management LLC's holdings in DaVita were worth $200,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of DVA. Transcendent Capital Group LLC acquired a new position in DaVita in the 3rd quarter valued at $25,000. Blue Trust Inc. increased its stake in shares of DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company's stock worth $54,000 after acquiring an additional 119 shares during the period. Quarry LP purchased a new position in DaVita during the third quarter worth about $60,000. Venturi Wealth Management LLC lifted its position in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after purchasing an additional 152 shares during the period. Finally, Versant Capital Management Inc boosted its holdings in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after purchasing an additional 169 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Price Performance

Shares of DVA stock traded down $0.08 during midday trading on Tuesday, reaching $141.96. 437,492 shares of the company traded hands, compared to its average volume of 839,433. The firm's 50 day simple moving average is $160.86 and its two-hundred day simple moving average is $158.19. The firm has a market cap of $11.36 billion, a PE ratio of 13.22, a price-to-earnings-growth ratio of 1.07 and a beta of 0.93. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a 1-year low of $124.42 and a 1-year high of $179.60.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities research analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Barclays increased their target price on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. Cowen reaffirmed a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $162.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.